Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
High-risk human papillomavirus (HPV) types are responsible for nearly all cases of cervical cancers. Cervarix® and Gardasil® 9 are the current prophylactic vaccines available that protect against the majority of HPVs associated with cancer. Although these vaccines are highly effective, HPV vaccine i...
Main Authors: | Nitesh K. Kunda, Julianne Peabody, Lukai Zhai, Dominique N. Price, Bryce Chackerian, Ebenezer Tumban, Pavan Muttil |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-08-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1593727 |
Similar Items
-
Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51
by: Rashi Yadav, et al.
Published: (2021-06-01) -
Impact of HPV vaccination with Gardasil® in Switzerland
by: Martine Jacot-Guillarmod, et al.
Published: (2017-12-01) -
Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017-06-01) -
Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort
by: Alltalents T. Murahwa, et al.
Published: (2024-01-01) -
Human Papillomavirus Vaccines: An Updated Review
by: Liqin Cheng, et al.
Published: (2020-07-01)